 |
|||
 |
 |
 |
|
Hepatitis C
HCV Pre-clinical Program
We are also focusing our research on the treatment of hepatitis C virus (HCV)
infection based on HCV-entry inhibition (i.e. preventing HCV from entering
healthy immune system cells).
Our research and development team has built a robust platform for HCV drug
discovery. We anticipate selecting a development candidate for the treatment of
HCV from a pre-clinical portfolio of candidates.